Newborn affected by maternal use of anxiolytics

This code signifies a newborn experiencing adverse effects due to the mother's use of anxiolytic medications during pregnancy or breastfeeding. These effects can range from withdrawal symptoms like tremors, irritability, and feeding difficulties, to respiratory depression or hypotonia, directly attributable to the maternal drug exposure.

Apply this code when documentation clearly indicates a newborn's clinical presentation is a direct consequence of maternal anxiolytic use. This typically occurs when the mother has a documented history of anxiolytic medication use during pregnancy or lactation, and the infant exhibits symptoms consistent with drug exposure or withdrawal.

• Always sequence this code as a secondary diagnosis, following the code for the newborn's specific symptoms or condition (e.g., withdrawal symptoms).
• Ensure documentation specifies the maternal anxiolytic use and a causal link to the newborn's condition.
• Do not use this code for general maternal drug use without specific anxiolytic involvement or for conditions unrelated to the maternal medication.